We focus on therapies for the treatment of bronchopulmonary disease
This section of the website provides information for existing and potential investors in Vectura Group plc including financial reports, an interactive share price chart and updates on our latest news.
Vectura's focused application of technology, know-how and expertise has demonstrated that the potential for new inhaled pharmaceuticals with real therapeutic and commercial value can be realised.
Vectura Investor Day, 26th March 2014
Vectura Group plc interim results for the six months ending 30 September 2013
Annual Report and Accounts for Year Ended 31 March 2013
01 Apr 2014
The smart nebuliser FOX wins Red Dot Design Award
13 Mar 2014
Acquisition of Activaero
11 Apr 2014
FAVOLIR Regulatory Update
03 Apr 2014
Blocklisting Interim Review
Share price table
Final Results for the year ending 31 March 2014
Annual General Meeting
Stay informed Register to our news alert and receive latest updates on news and events
For general enquiries, call us on +44 (0)1249 667700. For more specific enquiries, visit Contact us
Most computers will open PDF documents automatically, but you may need to download Adobe Reader.